Gaps Found In Most Pharma Trial Diversity Policies
A study suggests industry groups like PhRMA could use more of their influence to hold members accountable on trial diversity policies.

A study suggests industry groups like PhRMA could use more of their influence to hold members accountable on trial diversity policies.